Ravi Ojha

2.4k total citations
8 papers, 93 citations indexed

About

Ravi Ojha is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Ravi Ojha has authored 8 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Ravi Ojha's work include SARS-CoV-2 and COVID-19 Research (4 papers), interferon and immune responses (3 papers) and Long-Term Effects of COVID-19 (3 papers). Ravi Ojha is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), interferon and immune responses (3 papers) and Long-Term Effects of COVID-19 (3 papers). Ravi Ojha collaborates with scholars based in Finland, Australia and United States. Ravi Ojha's co-authors include Giuseppe Balistreri, Olli Vapalahti, Alex J.B. Kreutzberger, Tomas Kirchhausen, Jesse D. Pyle, Anwesha Sanyal, Suvi Kuivanen, Dario Greco, Ervin Tasnádi and Chuchu Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Virology.

In The Last Decade

Ravi Ojha

7 papers receiving 91 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravi Ojha Finland 5 58 29 17 15 13 8 93
Joseph W. Guarnieri United States 5 71 1.2× 53 1.8× 29 1.7× 16 1.1× 19 1.5× 7 137
Ziruo Sun China 3 29 0.5× 12 0.4× 10 0.6× 13 0.9× 15 1.2× 4 58
M. Sabri Hamad Cyprus 2 52 0.9× 15 0.5× 6 0.4× 8 0.5× 11 0.8× 2 75
Karthikeyan Dhamotharan Germany 5 20 0.3× 40 1.4× 9 0.5× 6 0.4× 6 0.5× 8 72
Ioannis Koutsodimitropoulos Greece 2 40 0.7× 18 0.6× 9 0.5× 12 0.8× 14 1.1× 2 60
Ka-Li Zhu China 5 69 1.2× 25 0.9× 8 0.5× 7 0.5× 19 1.5× 8 83
Haley B. Williams United States 4 54 0.9× 47 1.6× 11 0.6× 7 0.5× 4 0.3× 9 84
Aamir Fahira China 5 26 0.4× 51 1.8× 3 0.2× 14 0.9× 12 0.9× 22 106
Yiyuan Xu China 4 35 0.6× 63 2.2× 6 0.4× 6 0.4× 8 0.6× 7 101
Conghui Wang China 6 63 1.1× 22 0.8× 10 0.6× 13 0.9× 5 0.4× 12 119

Countries citing papers authored by Ravi Ojha

Since Specialization
Citations

This map shows the geographic impact of Ravi Ojha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Ojha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Ojha more than expected).

Fields of papers citing papers by Ravi Ojha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Ojha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Ojha. The network helps show where Ravi Ojha may publish in the future.

Co-authorship network of co-authors of Ravi Ojha

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Ojha. A scholar is included among the top collaborators of Ravi Ojha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Ojha. Ravi Ojha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ojha, Ravi, Eugen Timin, Leonóra Szirovicza, Wujun Xu, & Jussi Hepojoki. (2025). A systematic comparison of in-house prepared transfection reagents in the delivery of mRNA or DNA to a wide range of cultured cells. Journal of Biological Chemistry. 301(12). 110742–110742.
2.
Shen, Lu, Ravi Ojha, Markus Kaiser, et al.. (2024). Structure function analysis of ADP-dependent cyanobacterial phosphofructokinase reveals new phylogenetic grouping in the PFK-A family. Journal of Biological Chemistry. 300(11). 107868–107868. 3 indexed citations
3.
Kettunen, Pinja, Ravi Ojha, Markku Laakso, et al.. (2023). SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase. Journal of Virology. 97(4). e0014423–e0014423. 16 indexed citations
4.
Nekoua, Magloire Pandoua, Famara Sané, Grace Campagnola, et al.. (2023). Vemurafenib Inhibits Acute and Chronic Enterovirus Infection by Affecting Cellular Kinase Phosphatidylinositol 4-Kinase Type IIIβ. Microbiology Spectrum. 11(4). e0055223–e0055223. 1 indexed citations
5.
Kuivanen, Suvi, Riikka Lampinen, Tomáš Hron, et al.. (2023). Human-derived air–liquid interface cultures decipher Alzheimer’s disease–SARS-CoV-2 crosstalk in the olfactory mucosa. Journal of Neuroinflammation. 20(1). 299–299. 5 indexed citations
6.
Yang, Kailu, Chuchu Wang, Alex J.B. Kreutzberger, et al.. (2022). Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein. Proceedings of the National Academy of Sciences. 119(40). e2210990119–e2210990119. 27 indexed citations
7.
Serra, Angela, Michele Fratello, Antonio Federico, et al.. (2021). Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation. Briefings in Bioinformatics. 23(1). 14 indexed citations
8.
Kreutzberger, Alex J.B., Anwesha Sanyal, Ravi Ojha, et al.. (2021). Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease. Journal of Virology. 95(21). e0097521–e0097521. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026